A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Mefenamic acid
Dihydroergocristine
The metabolism of Dihydroergocristine can be decreased when combined with Nefazodone.
Mefenamic acid
Methylprednisone
The metabolism of Methylprednisone can be decreased when combined with Nefazodone.
Mefenamic acid
9-aminocamptothecin
The metabolism of 9-aminocamptothecin can be decreased when combined with Nefazodone.
Mefenamic acid
Dihydroergocornine
The metabolism of Dihydroergocornine can be decreased when combined with Nefazodone.
Mefenamic acid
Vitamin D
The metabolism of Vitamin D can be decreased when combined with Nefazodone.
Mefenamic acid
Tenofovir alafenamide
The metabolism of Tenofovir alafenamide can be decreased when combined with Nefazodone.
Mefenamic acid
Nintedanib
The metabolism of Nintedanib can be decreased when combined with Nefazodone.
Mefenamic acid
Tasimelteon
The metabolism of Tasimelteon can be decreased when combined with Nefazodone.
Mefenamic acid
Netupitant
The metabolism of Netupitant can be decreased when combined with Nefazodone.
Mefenamic acid
Lacosamide
The metabolism of Lacosamide can be decreased when combined with Nefazodone.
Mefenamic acid
Roflumilast
The metabolism of Roflumilast can be decreased when combined with Nefazodone.
Mefenamic acid
Allylestrenol
The metabolism of Allylestrenol can be decreased when combined with Nefazodone.
Mefenamic acid
Pranlukast
The metabolism of Pranlukast can be decreased when combined with Nefazodone.
Mefenamic acid
Drospirenone
The metabolism of Drospirenone can be decreased when combined with Nefazodone.
Mefenamic acid
St. John's Wort
The metabolism of Nefazodone can be decreased when combined with St. John's Wort.
Mefenamic acid
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Ubidecarenone.
Mefenamic acid
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Clinafloxacin.
Mefenamic acid
Cibenzoline
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Cibenzoline.
Mefenamic acid
Lanreotide
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Lanreotide.
Mefenamic acid
Pasireotide
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Pasireotide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3